Affiliated with Université Laval & CERVO Research Centre


Robert Bonin - Jeune chercheur étoile FRQ-S in Curium

A report about Robert Bonin was published in Curium, a scientific magazine targeting youth.  In the article, professor Bonin explains what is chronic pain, and results of his research to better understand it, and to improve its treatment.  Read the article here (in French only):  Robert Bonin - Jeune chercheur étoiles des Fonds de recherche du Québec


Yves De Koninck and Rob Bonin honoured at the Canadian Pain Society Meeting

Robert Bonin and Yves De Koninck

The Canadian Pain Society highlighted the research accomplishments of Yves De Koninck and Robert Bonin, a YDK lab alumnus and professor at University of Toronto, at their annual meeting, which took place May 23-26 in Halifax.  Congratulations to Professor De Koninck, who received the Distinguished Career Award, and to Professor Bonin, who received the Early Career Investigator Pain Research Grant. 

Yves De Koninck explique ses découvertes récentes à la radio

Écoutez une entrevue récente avec Yves De Koninck qui explique comment ses recherches récentes ont permis de trouver une cible thérapeutique qui permettrait de diminuer les symptômes du sevrage aux opioïdes, comme la morphine et le fentanyl.  Cette découverte, qui a aussi permis d'identifier des médicaments déjà approuvés pour l'utilisation chez l'humain, pourrait permettre d'accélérer l'approbation de médicaments pour traiter les symptômes du sevrage de plusieurs années.

Écoutez l'entrevue sur

New publication in Nature Medicine shows existing drugs can alleviate morphine withdrawal

A recent publication in Nature Medicine co-authored by Robert Bonin and Yves De Koninck offers new hope for people addicted to morphine and fentanyl.  By  investigating the underlying causes of withdrawal symptoms, the researchers identified a protein located in immune cells of the spinal cord called pannexin-1 as a major player, which lead them to look for drugs that block pannexin-1 as a way to alleviate symptoms.  The team found a drug previously approved to treat gout, called probenecid, that worked in this way.

Yves De Koninck will receive the Distinguished Career Award from the Canadian Pain Society

The director of the Neurophotonics Centre, Yves De Koninck, will receive the Canadian Pain Society's 2017 Distinguished Career Award. This award recognizes Dr. De Koninck's longstanding contributions to pain research.
The award will be given at the next Canadian Pain Society meeting, in May 2017 in Halifax.

Cover of Journal of Neuroscience

The Journal of Neuroscience has recently featured on its front page a figure from an article De Koninck laboratory members contributed to. The article studies the localisation of a specific receptor on neurons, the Coxsackievirus Adenovirus Receptor (CAR), in healthy brains, but also during development and in neurodegenerative disease conditions. The study suggests CAR has a role in adult neurogenesis, synapses, and plasticity in the hippocampus.

Sentinel North featured in Le Devoir newspaper

Sentinel North, a research initiative led by Yves De Koninck and Marcel Babin from Université Laval, and funded through the Canada First Research Excellence Fund, aims to better understand the Canadian North through the use of advanced optics technologies.  Its goal is to improve our understanding of humanity, its environment and the impact environmental changes are having on humans and their health in the North. Sentinel North was recently awarded $98 million over seven years, the largest subsidy in the history of Université Laval.

We celebrate 10 years of optogenetics research with Karl Deisseroth

Karl Deisseroth, Yves De Koninck, Valentin Nagerl

We had the pleasure to celebrate the 10th anniversary of optogenetics research with Karl Deisseroth, who delivered the Keynote and Public lecture at the recent Frontiers in Neurophotonics Symposium.  FINS2015 was held October 3-6 in Québec city.

On the picture, Karl Deisseroth, Yves De Koninck and Valentin Nägerl celebrate with a 10th anniversary cake.  

Yves De Koninck appointed to the Royal Society of Canada

Yves De Koninck was recently appointed to the Royal Society of Canada for "seminal contributions to understanding how neurons communicate at the cellular and molecular levels, in normal and pathological pain. Equally ground-breaking are his contributions to developing novel photonics technologies to push the frontiers of neuroscience".

View the Royal Society of Canada - Class of 2015 full listing.